Michael Markl1, Daniel C Lee2, Nicholas Furiasse2, Maria Carr2, Charles Foucar2, Jason Ng2, James Carr2, Jeffrey J Goldberger2. 1. From the Department of Radiology, Feinberg School of Medicine (M.M., D.C.L., M.C., J.C.), Department of Biomedical Engineering, McCormick School of Engineering (M.M.), Division of Cardiology, Feinberg School of Medicine (D.C.L., N.F., C.F., J.N., J.J.G.), and Feinberg Cardiovascular Research Institute (D.C.L., J.N., J.J.G.), Northwestern University, Chicago, IL; and Division of Cardiology, Department of Medicine, University of Miami Miller School of Medicine, FL (J.J.G.). mmarkl@northwestern.edu. 2. From the Department of Radiology, Feinberg School of Medicine (M.M., D.C.L., M.C., J.C.), Department of Biomedical Engineering, McCormick School of Engineering (M.M.), Division of Cardiology, Feinberg School of Medicine (D.C.L., N.F., C.F., J.N., J.J.G.), and Feinberg Cardiovascular Research Institute (D.C.L., J.N., J.J.G.), Northwestern University, Chicago, IL; and Division of Cardiology, Department of Medicine, University of Miami Miller School of Medicine, FL (J.J.G.).
Abstract
BACKGROUND: Atrial 4D flow magnetic resonance imaging was used for the characterization of left atrial (LA) and left atrial appendage (LAA) flow dynamics in patients with atrial fibrillation (AF). METHODS AND RESULTS: 4D flow magnetic resonance imaging measured in vivo 3D blood flow velocities in 60 AF patients and 15 controls. Anatomic maps of LA and LAA stasis and velocity were calculated to quantify atrial peak velocity, mean velocity, and stasis (velocities <0.1 m/s). In a substudy with 30 AF patients, 4D flow metrics were compared with Doppler transesophageal echocardiography. For all 15 controls, LAA mean and peak velocities were consistently lower (by 21%/12%; P<0.001) while LAA stasis was higher (by 58%; P<0.001) compared with the LA. In contrast, lower LAA velocity and increased LAA stasis were only found in a fraction (38 of 60) of AF patients. In AF patients, increased CHA2DS2-VASc score was associated with significantly (P<0.043) reduced LA velocities and elevated stasis. There was a heterogeneous expression of atrial flow dynamics, and 25% to 68% of AF patients demonstrated flow in the normal range: 25%/68% for LA/LAA stasis and 38%/60% for LA/LAA peak velocities. Transesophageal echocardiography velocities modestly but significantly (P<0.05) correlated with 4D flow-based LA velocities (r=0.41) and stasis (r=-0.39). CONCLUSIONS: AF resulted in overall impaired but individually variable flow dynamics in both the LA and LAA. AF patients demonstrated atrial flow in the normal range, despite elevated CHA2DS2-VASc score.
BACKGROUND: Atrial 4D flow magnetic resonance imaging was used for the characterization of left atrial (LA) and left atrial appendage (LAA) flow dynamics in patients with atrial fibrillation (AF). METHODS AND RESULTS: 4D flow magnetic resonance imaging measured in vivo 3D blood flow velocities in 60 AFpatients and 15 controls. Anatomic maps of LA and LAA stasis and velocity were calculated to quantify atrial peak velocity, mean velocity, and stasis (velocities <0.1 m/s). In a substudy with 30 AFpatients, 4D flow metrics were compared with Doppler transesophageal echocardiography. For all 15 controls, LAA mean and peak velocities were consistently lower (by 21%/12%; P<0.001) while LAA stasis was higher (by 58%; P<0.001) compared with the LA. In contrast, lower LAA velocity and increased LAA stasis were only found in a fraction (38 of 60) of AFpatients. In AFpatients, increased CHA2DS2-VASc score was associated with significantly (P<0.043) reduced LA velocities and elevated stasis. There was a heterogeneous expression of atrial flow dynamics, and 25% to 68% of AFpatients demonstrated flow in the normal range: 25%/68% for LA/LAA stasis and 38%/60% for LA/LAA peak velocities. Transesophageal echocardiography velocities modestly but significantly (P<0.05) correlated with 4D flow-based LA velocities (r=0.41) and stasis (r=-0.39). CONCLUSIONS:AF resulted in overall impaired but individually variable flow dynamics in both the LA and LAA. AFpatients demonstrated atrial flow in the normal range, despite elevated CHA2DS2-VASc score.
Authors: Rebecca T Hahn; Theodore Abraham; Mark S Adams; Charles J Bruce; Kathryn E Glas; Roberto M Lang; Scott T Reeves; Jack S Shanewise; Samuel C Siu; William Stewart; Michael H Picard Journal: J Am Soc Echocardiogr Date: 2013-09 Impact factor: 5.251
Authors: P G Walker; G B Cranney; M B Scheidegger; G Waseleski; G M Pohost; A P Yoganathan Journal: J Magn Reson Imaging Date: 1993 May-Jun Impact factor: 4.813
Authors: Jacob U Fluckiger; Jeffrey J Goldberger; Daniel C Lee; Jason Ng; Richard Lee; Amita Goyal; Michael Markl Journal: J Magn Reson Imaging Date: 2013-01-04 Impact factor: 4.813
Authors: Jeffrey J Goldberger; Rishi Arora; David Green; Philip Greenland; Daniel C Lee; Donald M Lloyd-Jones; Michael Markl; Jason Ng; Sanjiv J Shah Journal: Circulation Date: 2015-07-28 Impact factor: 29.690
Authors: Andrew Schluchter; Chelsea Jan; Katherine Lowe; Davis M Vigneault; Francisco Contijoch; Elliot R McVeigh Journal: Circ Cardiovasc Imaging Date: 2019-12-17 Impact factor: 7.792
Authors: Thomas Wehrum; Felix Guenther; Alexander Fuchs; Florian Schuchardt; Anja Hennemuth; Andreas Harloff Journal: Int J Cardiovasc Imaging Date: 2018-01-11 Impact factor: 2.357
Authors: Aakash N Gupta; Gilles Soulat; Ryan Avery; Bradley D Allen; Jeremy D Collins; Lubna Choudhury; Robert O Bonow; James Carr; Michael Markl; Mohammed S M Elbaz Journal: Int J Cardiovasc Imaging Date: 2021-02-01 Impact factor: 2.357
Authors: Margaret E McCormick; Elisabetta Manduchi; Walter R T Witschey; Robert C Gorman; Joseph H Gorman; Yi-Zhou Jiang; Christian J Stoeckert; Alex J Barker; Samuel Yoon; Michael Markl; Peter F Davies Journal: J Biomech Date: 2016-11-16 Impact factor: 2.712
Authors: Dominik C Benz; Paola Ferro; Nico Safa; Michael Messerli; Elia von Felten; Wenjie Huang; Dimitri Patriki; Andreas A Giannopoulos; Tobias A Fuchs; Christoph Gräni; Catherine Gebhard; Aju P Pazhenkottil; Philipp A Kaufmann; Ronny R Buechel Journal: J Nucl Cardiol Date: 2019-03-20 Impact factor: 5.952
Authors: Timothy M Bateman; Gary V Heller; Rob Beanlands; Dennis A Calnon; James Case; Rob deKemp; E Gordon DePuey; Marcelo Di Carli; Emel C Guler; Venkatesh L Murthy; Jeffrey Rosenblatt; Ronald Sher; Piotr Slomka; Terrence D Ruddy Journal: J Nucl Cardiol Date: 2021-03-30 Impact factor: 5.952